Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00205036
First received: September 13, 2005
Last updated: December 26, 2007
Last verified: December 2007
  Purpose

We, the investigators at the University of Wisconsin, hypothesized that ingesting calcium tablets prior to a spine bone density scan will not affect the bone mineral density as measured by dual energy x-ray absorptiometry (DXA).


Condition
Healthy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Study Start Date: January 2005
Detailed Description:

We hypothesized that ingesting calcium tablets prior to a spine bone density scan will not affect the bone mineral density as measured by DXA. To test this, 36 subjects ingested various calcium supplements after a spine DXA scan and were then scanned again 15, 30 and 45 minutes after ingestion. Subsequently a subset of 15 subjects had three spine scans performed for instrument precision and subsequently ingested a calcium tablet with scans 15 and 30 minute intervals after ingestion.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men or women 18 years or older

Exclusion Criteria:

  • Internal spinal hardware
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205036

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Neil C Binkley, MD University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Neil Binkley, MD, University of Wisconsin
ClinicalTrials.gov Identifier: NCT00205036     History of Changes
Other Study ID Numbers: M2004-1308
Study First Received: September 13, 2005
Last Updated: December 26, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on August 18, 2014